Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Kidney Disease Stage 2”

338 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 338 results

Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT02218099
What this trial is testing

Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease

Who this might be right for
Healthy SubjectsPharmacokinetics of ASP8232Pharmacodynamics of ASP8232+2 more
Astellas Pharma Europe B.V. 55
Testing effectiveness (Phase 2)Study completedNCT03054337
What this trial is testing

Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD)

Who this might be right for
AnemiaNon-dialysis Dependent Chronic Kidney Disease
Akebia Therapeutics 51
Testing effectiveness (Phase 2)Study completedNCT00646932
What this trial is testing

Paricalcitol Injection Phase II Trial

Who this might be right for
Chronic Kidney Disease
Abbott 25
Not applicableNot Yet RecruitingNCT07518719
What this trial is testing

Feasibility of The Health Integrated Nutrition and Kidney Wellness Program

Who this might be right for
Chronic Kidney DiseaseCardiovascular Disease
University of Pittsburgh 45
Large-scale testing (Phase 3)Active Not RecruitingNCT05369975
What this trial is testing

Efficacy and Safety in Imlifidase Desensitized Kidney Tx Patients, Including Two Non-Comparative Reference Cohorts

Who this might be right for
Kidney Transplantation in Highly Sensitized Patients
Hansa Biopharma AB 225
Large-scale testing (Phase 3)UnknownNCT01922999
What this trial is testing

Different Doses of Oral Melatonin Supplements in Chronic Kidney Disease (CKD)-Associated Sleep Disorders

Who this might be right for
End Stage Renal DiseaseChronic Kidney DiseaseSleep Disorder
Southeast Renal Research Institute 53
Large-scale testing (Phase 3)Active Not RecruitingNCT06077864
What this trial is testing

Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

Who this might be right for
Obesity
Boehringer Ingelheim 5,533
Testing effectiveness (Phase 2)Study completedNCT00228449
What this trial is testing

Peginesatide for Anemia in Chronic Hemodialysis Patients

Who this might be right for
AnemiaChronic Kidney DiseaseChronic Renal Failure
Affymax 165
Testing effectiveness (Phase 2)Study completedNCT00677092
What this trial is testing

Pilot Study of Imatinib Mesylate to Treat Nephrogenic Systemic Fibrosis

Who this might be right for
Nephrogenic Systemic Fibrosis
Massachusetts General Hospital 12
Not applicableWithdrawnNCT00898612
What this trial is testing

Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant

Who this might be right for
Lymphoma
Mayo Clinic
Testing effectiveness (Phase 2)Looking for participantsNCT06942910
What this trial is testing

Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Participants With Chronic Kidney Disease and High Proteinuria

Who this might be right for
Chronic Kidney Disease With High Proteinuria
AstraZeneca 224
Testing effectiveness (Phase 2)WithdrawnNCT05599815
What this trial is testing

Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome
Aldeyra Therapeutics, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT04580420
What this trial is testing

Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

Who this might be right for
Primary Hyperoxaluria Type 1End Stage Renal Disease
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 28
Not applicableStudy completedNCT03519347
What this trial is testing

Reducing Arrhythmia in Dialysis by Adjusting the Rx Electrolytes/Ultrafiltration, Study A

Who this might be right for
End Stage Renal Disease
NYU Langone Health 19
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06072326
What this trial is testing

DApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation

Who this might be right for
Type 1 Diabetes Mellitus With Diabetic Nephropathy
University Medical Center Groningen 36
Early research (Phase 1)Study completedNCT01464320
What this trial is testing

Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine.

Who this might be right for
Type 2 Diabetics, Chronic Kidney Disease, Protein in Urine
Abbott 16
Testing effectiveness (Phase 2)Study completedNCT03366337
What this trial is testing

Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX

Who this might be right for
IgA NephropathyCKD Associated With Type 1 DiabetesFocal Segmental Glomerulosclerosis+1 more
Biogen 103
Not applicableUnknownNCT04943081
What this trial is testing

Percutaneous Nephrolithotomy in Patients With Stage 2-4 Chronic Kidney Disease

Who this might be right for
Percutaneous Nephrolithotomy
Assiut University 50
Testing effectiveness (Phase 2)Study completedNCT04534114
What this trial is testing

Factor XI LICA to Reduce Events Such as Heart Attack and Stroke in Patients Whose Kidneys Are no Longer Able to Work as They Should and Require Treatment to Filter Wastes From the Blood: Focus is on the Safety of BAY2976217 and the Way the Body Absorbs, Distributes and Removes the Study Drug

Who this might be right for
End Stage Renal Disease Requiring Hemodialysis
Bayer 307
Load More Results